Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

193.08 -0.68 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 930,213
Open 194.30
Bid (Size) 192.00 (200)
Ask (Size) 196.00 (200)
Prev. Close 193.76
Today's Range 192.27 - 195.50
52wk Range 121.05 - 205.97
Shares Outstanding 146,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
From Pomerantz LLP
Via GlobeNewswire
News headline image
MarketBeat Week in Review – 05/18 - 05/22 ↗
Stocks were up sharply to end the week as NVIDIA’s forward guidance showed tangible demand to support AI infrastructure and overshadowed mixed retail reports 
Via MarketBeat
Topics Artificial Intelligence Economy

Performance

YTD
+8.6%
+8.6%
1 Month
+6.9%
+6.9%
3 Month
-1.1%
-1.1%
6 Month
+6.1%
+6.1%
1 Year
+50.4%
+50.4%

More News

Read More
News headline image
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish ↗
Via MarketBeat
Unusual volume S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
From Denali Therapeutics Inc.
Via GlobeNewswire
News headline image
BIIB Investor Alert: Levi & Korsinsky Investigates Biogen Inc. (BIIB) for Potential Securities Fraud
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗
Via MarketBeat
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Best Healthcare Stocks to Buy in 2026 ↗
Via The Motley Fool
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Discover the top S&P500 movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Via Investor Brand Network
Topics Intellectual Property
News headline image
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
From BioMedWire
Via GlobeNewswire
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
News headline image
3 Value Stocks We Approach with Caution
Via StockStory
News headline image
Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings ↗
Via Benzinga
News headline image
Why Biogen Stock Was a Winner on Wednesday ↗
Via The Motley Fool
News headline image
Biogen (BIIB) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales
Via StockStory
Topics Artificial Intelligence
News headline image
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks We Steer Clear Of
Via StockStory
News headline image
Biogen (BIIB) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 193.08
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 05/26/26 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 28.34B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 28B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.